U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 4-10, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 4-10, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 08/08/2024
Location: Washington, DC
Subject: Medical Products and Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Gene Dodaro, Jessica Farb, John Dicken, Mary Denigan-McCauley, Orice Williams Brown (U.S. Government Accountability Office);

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

No Significant Event

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 08/06/2024
Location: Silver Spring, MD
Subject: Artificial Intelligence (AI) in Drug and Biological Product Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Clinical Trials Transformation Initiative (CTTI)

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 08/06/2024
Location: Virtual
Subject: Centers for Medicare and Medicaid Services; Panel Discussion for Immunization Outreach Efforts
FDA Participant/Group: N/A
Non FDA Participant/Group: Community-based organizations, health professionals, and government stakeholders

Event Date: 08/08/2024
Location: Virtual
Subject: Clinicians Connect: Conversations with FDA’s Chief Medical Officer: Fall Respiratory Virus Season
FDA Participant/Group: HILARY MARSTON;
Non FDA Participant/Group: Clinician stakeholders

Official Name: Michelle Tarver, M.D., Ph.D,, Acting Director, Center for Devices and Radiological Health

Event Date: 08/08/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: JEFFREY SHUREN;
Non FDA Participant/Group: Karin Hoelzer, Heidi Ross, Pamela Gavin, Peter Saltonstall (National Organization for Rare Disorders)

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 08/07/2024
Location: Virtual
Subject: House Committee on Energy and Commerce Minority Briefing; FDA Tobacco Programmatic Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the House Committee on Energy and Commerce

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top